1. Home
  2. CRGX vs ESQ Comparison

CRGX vs ESQ Comparison

Compare CRGX & ESQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • ESQ
  • Stock Information
  • Founded
  • CRGX 2021
  • ESQ 2006
  • Country
  • CRGX United States
  • ESQ United States
  • Employees
  • CRGX N/A
  • ESQ N/A
  • Industry
  • CRGX
  • ESQ Commercial Banks
  • Sector
  • CRGX
  • ESQ Finance
  • Exchange
  • CRGX Nasdaq
  • ESQ Nasdaq
  • Market Cap
  • CRGX 621.4M
  • ESQ 638.2M
  • IPO Year
  • CRGX 2023
  • ESQ 2017
  • Fundamental
  • Price
  • CRGX $11.70
  • ESQ $80.18
  • Analyst Decision
  • CRGX Strong Buy
  • ESQ Buy
  • Analyst Count
  • CRGX 6
  • ESQ 4
  • Target Price
  • CRGX $31.80
  • ESQ $70.00
  • AVG Volume (30 Days)
  • CRGX 293.5K
  • ESQ 61.8K
  • Earning Date
  • CRGX 11-12-2024
  • ESQ 01-23-2025
  • Dividend Yield
  • CRGX N/A
  • ESQ 0.76%
  • EPS Growth
  • CRGX N/A
  • ESQ 2.35
  • EPS
  • CRGX N/A
  • ESQ 4.95
  • Revenue
  • CRGX N/A
  • ESQ $116,205,000.00
  • Revenue This Year
  • CRGX N/A
  • ESQ N/A
  • Revenue Next Year
  • CRGX N/A
  • ESQ $11.52
  • P/E Ratio
  • CRGX N/A
  • ESQ $15.84
  • Revenue Growth
  • CRGX N/A
  • ESQ 10.32
  • 52 Week Low
  • CRGX $11.80
  • ESQ $44.45
  • 52 Week High
  • CRGX $33.92
  • ESQ $82.56
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 33.03
  • ESQ 55.17
  • Support Level
  • CRGX $13.65
  • ESQ $76.97
  • Resistance Level
  • CRGX $15.75
  • ESQ $82.56
  • Average True Range (ATR)
  • CRGX 1.09
  • ESQ 2.19
  • MACD
  • CRGX -0.13
  • ESQ -0.23
  • Stochastic Oscillator
  • CRGX -0.40
  • ESQ 50.36

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. The Bank operates a payment processing platform through third-party Independent Sales Organizations.

Share on Social Networks: